Key Highlights

  • Published market coverage of the rating change says the firm lowered Nike to Sell, from Hold, on November 5, 2026, setting a USD 29 target.
  • Shares were reported to have gained about 19% across roughly a month, a stretch in which the S&P 500 was flat, and one closing summary put the session decline at 2.30%.
  • Truist reportedly linked the advance to rotation among out-of-favor stocks rather than to fundamentals, based on that same coverage.
  • The USD 29 target lies roughly 31% under the USD 42 figure Truist assigned on August 26, 2026, and that gap is calculated.

Downgrade Follows an Earlier Cut This Summer

On November 5, 2026, Truist lowered its stance on Nike (NYSE:NKE) to Sell from Hold, with a USD 29 price target. A single foreign-language article dated August 26, 2026 indicates that Truist had earlier moved Nike from Buy to Hold, lowering the target to USD 42 from USD 47. Both moves point the same way, so the firm is more cautious now than in late summer, and both come from the same research house. A Sell call means the firm expects the stock to trail the broader market over its forecast window, a view rather than a certainty. A target is one research firm's opinion and is cited here only as a data point. No verified Nike closing price was located, so no gap between price and target is calculated, though the move from USD 42 to USD 29 is a calculated reduction of about 31%.

Sector Rotation Explains the Rally, Reportedly

The downgrade followed a rise of roughly 19% in about a month, while the S&P 500 was flat, according to a single market summary. Truist reportedly attributed that run to money rotating into lagging names rather than to better results. Rotation can unwind quickly if the wider trade shifts. The August commentary flagged murky prospects for U.S. sporting goods retail after Dick's Sporting Goods lowered its 2026 guidance on softer footwear demand, plus heavier discounting across the sector. Rallies driven by flows rather than profit forecasts are frequently doubted, though no outcome is assured.

Turnaround Debate, Two-Way Risks and Next Catalysts

Athletic footwear, apparel and equipment make up Nike's business, and the turnaround plan sits at the heart of the debate. In August, Truist highlighted progress in clearing excess product and in a pipeline of new products for 2027. Risks cut both ways, including discounting, tariffs, wholesale partner inventory and consumer demand. A decline of about 2.30% on the session appears in only one closing summary, so it has not been independently confirmed. Investors will look to the next quarterly report, wholesale order trends and whether other firms follow with rating changes. A 2.30% slip is small beside the 19% run, though a single session says little about the weeks ahead. Readers should also note that the 2.30% figure was not checked against a second closing record.

Where Things Stand

Truist's view is that the rally outpaced the underlying business. Nike (NYSE:NKE) had advanced roughly 19% in a month when the firm moved it to Sell with a USD 29 target, and the firm reportedly tied the gain to sector rotation instead of better results. The stock slipped about 2.30% on Thursday by one account, a restrained response to a change of this size. A single research house does not settle the argument. Watch Nike's next report, holiday Demand and whether peers follow the call.